MEREO BIOPHARMA GROUP PLC's ticker is MREO and the CUSIP is 589492107. A total of 62 filers reported holding MEREO BIOPHARMA GROUP PLC in Q4 2022. The put-call ratio across all filers is 0.95 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $12,540 | +153.4% | 9,500 | +35.7% | 0.01% | +100.0% |
| Q1 2023 | $4,948 | +64.9% | 7,000 | +75.0% | 0.00% | +50.0% |
| Q4 2022 | $3,000 | 0.0% | 4,000 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $3,000 | -25.0% | 4,000 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $4,000 | 0.0% | 4,000 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $4,000 | -33.3% | 4,000 | 0.0% | 0.00% | -33.3% |
| Q4 2021 | $6,000 | -40.0% | 4,000 | 0.0% | 0.00% | -50.0% |
| Q3 2021 | $10,000 | -23.1% | 4,000 | 0.0% | 0.01% | -25.0% |
| Q2 2021 | $13,000 | 0.0% | 4,000 | 0.0% | 0.01% | -20.0% |
| Q1 2021 | $13,000 | – | 4,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vivo Capital, LLC | 6,220,938 | $16,299,000 | 0.94% |
| Boxer Capital, LLC | 4,029,649 | $10,558,000 | 0.36% |
| DAFNA Capital Management LLC | 199,425 | $522,000 | 0.17% |
| J. Goldman & Co LP | 443,517 | $1,162,000 | 0.08% |
| Ikarian Capital, LLC | 1,196,308 | $688,000 | 0.05% |
| HHLR ADVISORS, LTD. | 1,598,185 | $4,187,000 | 0.03% |
| BOOTHBAY FUND MANAGEMENT, LLC | 133,634 | $350,000 | 0.02% |
| F3Logic, LLC | 255 | $668,000 | 0.02% |
| Schonfeld Strategic Advisors LLC | 343,195 | $899,000 | 0.02% |
| CSS LLC/IL | 54,773 | $144,000 | 0.01% |